CD40 engagement on HRS cells increased both tumor growth and survival, upregulated CD54, CD80, and IRF4 expression, augmented the secretion of IL-8, TNF-α, IL-6, LT-α and CCL5, decreased Fas-mediated apoptosis and increased NF-kB activation [4]. The gene discussed is IRF4; the disease is neoplasm.